198 related articles for article (PubMed ID: 14982155)
1. Quantitative structure-toxicity relationships by accelerated cytotoxicity mechanism screening.
Siraki AG; Chevaldina T; Moridani MY; O'Brien PJ
Curr Opin Drug Discov Devel; 2004 Jan; 7(1):118-25. PubMed ID: 14982155
[TBL] [Abstract][Full Text] [Related]
2. A combined approach to drug metabolism and toxicity assessment.
Ekins S; Andreyev S; Ryabov A; Kirillov E; Rakhmatulin EA; Sorokina S; Bugrim A; Nikolskaya T
Drug Metab Dispos; 2006 Mar; 34(3):495-503. PubMed ID: 16381662
[TBL] [Abstract][Full Text] [Related]
3. Early prediction of drug metabolism and toxicity: systems biology approach and modeling.
Bugrim A; Nikolskaya T; Nikolsky Y
Drug Discov Today; 2004 Feb; 9(3):127-35. PubMed ID: 14960390
[TBL] [Abstract][Full Text] [Related]
4. [A new method for quantitative assessment of mechanisms of partitioning and absorption of drugs: linear solvation energy relationships].
Li J; Sun J; He ZG
Yao Xue Xue Bao; 2007 Jan; 42(1):13-8. PubMed ID: 17520801
[TBL] [Abstract][Full Text] [Related]
5. A neural networks-based drug discovery approach and its application for designing aldose reductase inhibitors.
Hu L; Chen G; Chau RM
J Mol Graph Model; 2006 Jan; 24(4):244-53. PubMed ID: 16226911
[TBL] [Abstract][Full Text] [Related]
6. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
[TBL] [Abstract][Full Text] [Related]
7. Comparative QSAR- and fragments distribution analysis of drugs, druglikes, metabolic substances, and antimicrobial compounds.
Karakoc E; Sahinalp SC; Cherkasov A
J Chem Inf Model; 2006; 46(5):2167-82. PubMed ID: 16995747
[TBL] [Abstract][Full Text] [Related]
8. Towards integrated ADME prediction: past, present and future directions for modelling metabolism by UDP-glucuronosyltransferases.
Smith PA; Sorich MJ; Low LS; McKinnon RA; Miners JO
J Mol Graph Model; 2004 Jul; 22(6):507-17. PubMed ID: 15182810
[TBL] [Abstract][Full Text] [Related]
9. Anticancer activity of selected phenolic compounds: QSAR studies using ridge regression and neural networks.
Nandi S; Vracko M; Bagchi MC
Chem Biol Drug Des; 2007 Nov; 70(5):424-36. PubMed ID: 17949360
[TBL] [Abstract][Full Text] [Related]
10. ANN-QSAR model of drug-binding to human serum albumin.
Deeb O; Hemmateenejad B
Chem Biol Drug Des; 2007 Jul; 70(1):19-29. PubMed ID: 17630991
[TBL] [Abstract][Full Text] [Related]
11. Studying the explanatory capacity of artificial neural networks for understanding environmental chemical quantitative structure-activity relationship models.
Yang L; Wang P; Jiang Y; Chen J
J Chem Inf Model; 2005; 45(6):1804-11. PubMed ID: 16309287
[TBL] [Abstract][Full Text] [Related]
12. Molecular binding interactions: their estimation and rationalization in QSARs in terms of theoretically derived parameters.
Lewis DF; Broughton HB
ScientificWorldJournal; 2002 Jun; 2():1776-802. PubMed ID: 12806170
[TBL] [Abstract][Full Text] [Related]
13. A novel in silico approach to drug discovery via computational intelligence.
Hecht D; Fogel GB
J Chem Inf Model; 2009 Apr; 49(4):1105-21. PubMed ID: 19348414
[TBL] [Abstract][Full Text] [Related]
14. Multi-dimensional QSAR in drug discovery.
Lill MA
Drug Discov Today; 2007 Dec; 12(23-24):1013-7. PubMed ID: 18061879
[TBL] [Abstract][Full Text] [Related]
15. Clustering and its application in multi-target prediction.
Liu W; Johnson DE
Curr Opin Drug Discov Devel; 2009 Jan; 12(1):98-107. PubMed ID: 19152218
[TBL] [Abstract][Full Text] [Related]
16. Skin permeation rate as a function of chemical structure.
Katritzky AR; Dobchev DA; Fara DC; Hür E; Tämm K; Kurunczi L; Karelson M; Varnek A; Solov'ev VP
J Med Chem; 2006 Jun; 49(11):3305-14. PubMed ID: 16722649
[TBL] [Abstract][Full Text] [Related]
17. The value of in silico chemistry in the safety assessment of chemicals in the consumer goods and pharmaceutical industries.
Modi S; Hughes M; Garrow A; White A
Drug Discov Today; 2012 Feb; 17(3-4):135-42. PubMed ID: 22063083
[TBL] [Abstract][Full Text] [Related]
18. In silico human and rat Vss quantitative structure-activity relationship models.
Gleeson MP; Waters NJ; Paine SW; Davis AM
J Med Chem; 2006 Mar; 49(6):1953-63. PubMed ID: 16539383
[TBL] [Abstract][Full Text] [Related]
19. Collaborative filtering on a family of biological targets.
Erhan D; L'heureux PJ; Yue SY; Bengio Y
J Chem Inf Model; 2006; 46(2):626-35. PubMed ID: 16562992
[TBL] [Abstract][Full Text] [Related]
20. Modeling the toxicity of chemicals to Tetrahymena pyriformis using heuristic multilinear regression and heuristic back-propagation neural networks.
Kahn I; Sild S; Maran U
J Chem Inf Model; 2007; 47(6):2271-9. PubMed ID: 17985864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
